Scientists largely funded by Breast Cancer Now have discovered three new genetic changes that increase the risk of breast cancer in men, furthering our understanding of this form of the disease.
We hear from Professor Rob Clarke, a Breast Cancer Now researcher based at the University of Manchester. He shares how the work in his lab restarted after over a three-month closure due to COVID-19.
Study has suggested that immunotherapy could be effective against some cancers with changes in BRCA genes that become resistant to treatment.
We hear from Dr Anna Git, a Breast Cancer Now scientist based at the University of Cambridge. She shares how her research has been put on hold after her lab closed due to COVID-19.
We speak to Dr Natasha Malik is a Breast Cancer Now researcher at the University of Glasgow who volunteered to join a coronavirus testing lab when her work was paused by the pandemic.
While a lot of lab-based research is currently on hold due to COVID-19, the Breast Cancer Now Generations Study continues.
A study has found that adding two hormone measurements to a breast cancer risk prediction tool can increase its accuracy for women aged 35-50.
We hear from Dr Niamh Buckley, a Breast Cancer Now Fellow based at Queen’s University Belfast. She shares how she has been working from home after her lab closed due to COVID-19.
Dr Simon Vincent, Director of Research at Breast Cancer Now, shares how COVID-19 has affected Breast Cancer Now’s research.